# Progress Note 03 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Srinivasa Ramanujan (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET020-SYN
- Date: 2026-01-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Edmund Ashworth, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Day 12: end of metronidazole and start of paromomycin, blood count, CRP and liver tests, mood and safety review. **S**

## History of present illness

Mr. Ramanujan returns at the end of ten days of metronidazole. At the nurse's call on the third day his fever had already broken, and he has had none since. The ache under his right ribs is much less and no longer catches his breath. Metronidazole gave him a metallic taste and some nausea, eased by taking it with food; he finished every dose three days ago and started paromomycin the next day, which has loosened his stools to twice a day. He asked about the capsule shells, which contain gelatin, and after discussion decided to take them as prescribed. He has no numbness or tingling. He met the dietitian and is cooking once a day for two meals. He has seen the counselor twice. He is sleeping better and has returned to his work for a few hours a day. **S**

| Element | Detail |
|---|---|
| Fever | Gone since the third day |
| Metronidazole | Completed; metallic taste and mild nausea |
| Paromomycin | Day 3 of 7; looser stools |
| Support | Dietitian once; counseling twice |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or sweats; appetite returning |
| Gastrointestinal | Positive | Mild right upper quadrant ache; two loose stools a day on paromomycin; no blood |
| Neurological | Negative | No numbness or tingling |
| Respiratory | Negative | No pain on breathing; no cough |
| Psychiatric | Positive | Mood a little better; still lonely; no thoughts of self-harm |

5 systems reviewed. **S**

## Current medications

- Paromomycin 250 mg oral capsule, two capsules (500 mg) three times a day with meals for 7 days, started the day after metronidazole ends **S**
- Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily **S**
- Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks **S**

## Allergies

- No known allergy **S**

## Objective

BP 114/72 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 98% on room air; weight 52.6 kg; BMI 19.3 kg/m². All vital signs are synthetic.

White blood cells: 8.9 10*3/uL; Hemoglobin: 11.6 g/dL (low); Platelets: 380 10*3/uL; C-reactive protein: 24 mg/L (high); Alkaline phosphatase: 168 U/L (high); ALT: 34 U/L; Albumin: 3.5 g/dL; PHQ-9: 10; GAD-7: 7. All results are synthetic.

## Change since baseline

- White blood cells: 13.6 10*3/uL (high) at baseline, 8.9 10*3/uL at this visit **S**
- Hemoglobin: 11.2 g/dL (low) at baseline, 11.6 g/dL (low) at this visit **S**
- Platelets: 412 10*3/uL (high) at baseline, 380 10*3/uL at this visit **S**
- C-reactive protein: 92 mg/L (high) at baseline, 24 mg/L (high) at this visit **S**
- Alkaline phosphatase: 214 U/L (high) at baseline, 168 U/L (high) at this visit **S**
- ALT: 46 U/L (high) at baseline, 34 U/L at this visit **S**
- Albumin: 3.2 g/dL (low) at baseline, 3.5 g/dL at this visit **S**
- PHQ-9: 12 at baseline, 10 at this visit **S**
- GAD-7: 9 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Better; temperature 36.8 °C, pulse 80; weight 52.6 kg |
| Respiratory | Breath sounds better at the right base |
| Abdomen | Liver edge 2 cm below the costal margin, mildly tender; less intercostal tenderness |
| Psychiatric | Quieter than most patients but brighter than at intake |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Amebic liver abscess** (A06.4). Good response: afebrile from day 3, pain much less. White cells 8.9, CRP 24 mg/L from 92; alkaline phosphatase 168 U/L from 214; ALT 34 U/L; albumin 3.5 g/dL. No imaging is needed while he improves. **S**
   - Finish paromomycin, two capsules three times a day, four more days.
   - Loose stools are expected; drink well.
2. **Vitamin B12 deficiency with anemia** (D51.3). Hemoglobin 11.6 g/dL from 11.2 and rising; platelets 380. A reticulocyte count one week after starting replacement was not ordered. **S**
   - Continue B12 1,000 micrograms daily.
   - Blood count at six weeks.
3. **Adjustment disorder with depressed mood** (F43.21). PHQ-9 10 and GAD-7 7, from 12 and 9. Safety reviewed: no thoughts of suicide or self-harm; safety plan current. **S**
   - Continue counseling weekly.
   - Call home on a fixed day each week, as he planned.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Temperature, symptoms and abdominal examination (liver tenderness, right lower rib tenderness) | Every visit | Completed today | Afebrile since day 3; liver less tender |
| Examination | Weight and BMI | Every visit | Completed today | 52.6 kg |
| Laboratory | Blood count and C-reactive protein | At diagnosis, at the end of the tissue course, then until normal | Completed today | White cells 8.9, hemoglobin 11.6, platelets 380; CRP 24 mg/L |
| Laboratory | Liver tests (alkaline phosphatase, ALT, AST, bilirubin, albumin) | At diagnosis, at the end of therapy, and before and during rifampin | Completed today | Alkaline phosphatase 168, ALT 34 U/L; albumin 3.5 g/dL |
| Imaging | Liver imaging | At diagnosis; repeat only for no response or a complication | Not indicated | Clinical response; imaging lags behind recovery and is not repeated |
| Laboratory | Sputum acid-fast smears, NAAT and mycobacterial cultures | Three samples at baseline; cultures final at 6 to 8 weeks | Up to date | Smears and NAAT negative; cultures no growth so far |
| Medication safety | Amebicide safety and completion (nausea, metallic taste, numbness on metronidazole; diarrhea on paromomycin; no overlap) | At the start and every visit during treatment | Completed today | Metronidazole completed with a metallic taste and mild nausea; no numbness; paromomycin day 3 with loose stools; no overlap |
| Laboratory | Response to vitamin B12 replacement | Reticulocyte count at 1 week; blood count at about 8 weeks; neurologic examination at diagnosis | Deferred | Missed: the reticulocyte count one week after starting B12 was not ordered. No harm judging by the rising hemoglobin today (11.6 from 11.2 g/dL) and a normal neurologic examination. Corrective action: none needed for this course; the blood count at about eight weeks confirms the response, and the replacement order set now includes the reticulocyte count |
| Self-management | Diet and weight plan within his vegetarian rules | Every visit | Completed today | Dietitian plan in use; cooking once a day for two meals |
| Survey | PHQ-9 and GAD-7 | At least monthly while symptoms are active | Completed today | PHQ-9 10, GAD-7 7 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current |
| Self-management | Support far from home (counseling, contact with family and community, department and fellowship) | Every visit | Completed today | Counseling twice; weekly call home planned; back at work part of the day |

## Goal progress

- A diagnosis within days, with tuberculosis either confirmed or excluded before any treatment that could hide it. In progress; target 2026-02-23. **S**
- No fever, the abscess treated, and the luminal course completed. In progress; target 2026-04-20. **S**
- Regain at least half of the lost weight within three months, on a diet that keeps his rules. In progress; target 2026-04-20. **S**
- Vitamin B12 and vitamin D in the normal range and the anemia resolved. In progress; target 2026-04-20. **S**
- PHQ-9 below 10 with no thoughts of self-harm, and regular contact with people who matter to him. In progress; target 2026-04-20. **S**
- Complete four months of rifampin for latent tuberculosis infection. In progress; target 2026-04-20. **S**

## Guideline basis

- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017), ATS, IDSA and CDC (Clin Infect Dis 2017)
- DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026), Centers for Disease Control and Prevention
- A Review of the Global Burden, New Diagnostics, and Current Therapeutics for Amebiasis (2018), Shirley DT et al., Open Forum Infect Dis 2018
- Position of the Academy of Nutrition and Dietetics: Vegetarian Diets (2016), Academy of Nutrition and Dietetics (J Acad Nutr Diet 2016)
- CMID: Clinical Monitoring Intelligence Database, anemia and depression monographs (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense

## Follow-up

- Review at six weeks with the final sputum cultures, blood count, liver tests, vitamin B12 and mood. Call for fever, return of the right-sided pain, or diarrhea that does not settle after paromomycin. **S**
- Next scheduled visit 2026-02-23: six weeks: recovery, final sputum cultures, liver tests before rifampin, vitamin B12, mood, influenza vaccine. **S**
